Neuromuscular Diseases Care in the Era of COVID-19

被引:25
|
作者
Bertran Recasens, Bernat [1 ]
Angel Rubio, Miguel [1 ]
机构
[1] Hosp del Mar, Neurol Dept, Neuromuscular Unit, Barcelona, Spain
来源
FRONTIERS IN NEUROLOGY | 2020年 / 11卷
关键词
neuromuscular disease (NMD); COVID-19; ALS (amyotrophic lateral sclerosis); CIDP; myasthenia gravis; telemedicine; telehealth; CRITICAL ILLNESS MYOPATHY; MYASTHENIA-GRAVIS;
D O I
10.3389/fneur.2020.588929
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The COVID-19 pandemic has pushed health systems to their limit and forced readjustment of standards of care for different pathologies. Management of neuromuscular diseases becomes a challenge since most of them are chronic, disabling, progressive, and/or require immunosuppressive drugs. There are three main aspects of COVID-19 that affect neuromuscular diseases care. The first one relates to how SARS-CoV2 directly affects different neuromuscular pathologies. Respiratory weakness, as seen in myasthenia gravis, amyotrophic lateral sclerosis, and myopathies, and the use of immunomodulatory drugs (Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy) make this group of patients potentially more vulnerable. Secondly, safety measures also affect proper care, limiting care continuity, and physical rehabilitation (one of the essential aspects of myopathies treatment). Telemedicine can partially solve the problem allowing for a continuum of close care, avoiding unnecessary visits, and even guaranteeing the attention of professionals from tertiary care centers. However, one of the crucial steps in neuromuscular diseases is diagnosis, and in most scenarios, more than one face-to-face visit is needed. Lastly, the global COVID-19 situation will also have an economic impact on patients and their families. This situation is of particular concern given that neuromuscular diseases already present difficulties due to the scarcity of resources in terms of public healthcare and research.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Care for Patients With Neuromuscular Disorders in the COVID-19 Pandemic Era
    Tseng, Yung-Hao
    Chen, Tai-Heng
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [2] COVID-19 heralds a new era for chronic diseases in primary care
    不详
    [J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (07): : 647 - 647
  • [3] Laryngectomy Care in the COVID-19 Era
    Sarsfield, Erin
    Montano, Melissa
    Choi, Karen
    Goyal, Neerav
    [J]. JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2020, 146 (08) : 776 - 776
  • [4] Epilepsy care in the COVID-19 era
    Adan, Guleed H.
    Mitchell, James W.
    Marson, Tony
    [J]. CLINICAL MEDICINE, 2020, 20 (04): : E104 - E106
  • [5] Wound care in the era of COVID-19
    Waller, Harold D.
    McCarthy, Maureen W.
    Goverman, Jeremy
    Kaafarani, Haytham
    Dua, Anahita
    [J]. JOURNAL OF WOUND CARE, 2020, 29 (08) : 432 - 434
  • [6] BACTERIAL INFECTIOUS DISEASES IN THE COVID-19 ERA
    Pinto, Tatiana C. A.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S39 - S40
  • [7] Technology and cardiovascular diseases in the era of COVID-19
    Harky, Amer
    Adan, Ahmed
    Mohamed, Malak
    Elmi, Asha
    Theologou, Thomas
    [J]. JOURNAL OF CARDIAC SURGERY, 2020, 35 (12) : 3551 - 3554
  • [8] COVID-19 as the trigger for respiratory failure in neuromuscular diseases
    de Carvalho, Marta Rodrigues
    Dal Berto, Beatriz Schmidt
    Santos, Priscila Leite
    de Azevedo, Guilherme Coelho
    Morato Fernandez, Rubens Nelson
    Grippe, Talyta
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (03) : 264 - 265
  • [9] Navigating Cancer Care in the COVID-19 Era
    Poh, Alissa
    [J]. CANCER DISCOVERY, 2022, 12 (02) : 283 - 283
  • [10] Retooling Primary Care in the COVID-19 Era
    Lin, Steven
    Sattler, Amelia
    Smith, Margaret
    [J]. MAYO CLINIC PROCEEDINGS, 2020, 95 (09) : 1831 - 1834